Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Judge

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
The Canadian Journal of Urology|September 26, 2008
Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancerChristopher J DiBlasio, Jessica Hammett, John B Malcolm, et al.
Osteoarthritis and Cartilage|January 15, 2014
Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort studyA Judge, R N Batra, G E Thomas, et al.
Osteoarthritis and Cartilage|July 23, 2014
Subclinical deformities of the hip are significant predictors of radiographic osteoarthritis and joint replacement in women. A 20 year longitudinal cohort studyG E R Thomas, A J R Palmer, R N Batra, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8Russell A Judge, Haizhong Zhu, Anup K Upadhyay, et al.
Southern African Journal of HIV Medicine|June 30, 2021
HIV infection in Eastern and Southern Africa: Highest burden, largest challenges, greatest potentialErica Parker, Melinda A Judge, Eusebio Macete, et al.
Journal of Biomolecular Screening|September 8, 2006
Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1Kenneth M Comess, Jonathan D Trumbull, Chang Park, et al.
The American Journal of Gastroenterology|January 5, 2002
An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitisJ D Lewis, G R Lichtenstein, R B Stein, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
N-aryl-benzimidazolones as novel small molecule HSP90 inhibitorsMilan Bruncko, Stephen K Tahir, Xiaohong Song, et al.
Bioorganic & Medicinal Chemistry|February 9, 2007
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitorsYunsong Tong, Akiyo Claiborne, Kent D Stewart, et al.
BMC Molecular and Cell Biology|August 7, 2019
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switchesMaria A Argiriadi, Lorenzo Benatuil, Ievgeniia Dubrovska, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
The Canadian Journal of Urology|September 26, 2008
Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancerChristopher J DiBlasio, Jessica Hammett, John B Malcolm, et al.
Osteoarthritis and Cartilage|January 15, 2014
Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort studyA Judge, R N Batra, G E Thomas, et al.
Osteoarthritis and Cartilage|July 23, 2014
Subclinical deformities of the hip are significant predictors of radiographic osteoarthritis and joint replacement in women. A 20 year longitudinal cohort studyG E R Thomas, A J R Palmer, R N Batra, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8Russell A Judge, Haizhong Zhu, Anup K Upadhyay, et al.
Southern African Journal of HIV Medicine|June 30, 2021
HIV infection in Eastern and Southern Africa: Highest burden, largest challenges, greatest potentialErica Parker, Melinda A Judge, Eusebio Macete, et al.
Journal of Biomolecular Screening|September 8, 2006
Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1Kenneth M Comess, Jonathan D Trumbull, Chang Park, et al.
The American Journal of Gastroenterology|January 5, 2002
An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitisJ D Lewis, G R Lichtenstein, R B Stein, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
N-aryl-benzimidazolones as novel small molecule HSP90 inhibitorsMilan Bruncko, Stephen K Tahir, Xiaohong Song, et al.
Bioorganic & Medicinal Chemistry|February 9, 2007
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitorsYunsong Tong, Akiyo Claiborne, Kent D Stewart, et al.
BMC Molecular and Cell Biology|August 7, 2019
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switchesMaria A Argiriadi, Lorenzo Benatuil, Ievgeniia Dubrovska, et al.
Pageof 23